Key facts
- This page summarizes Abbas Hussain's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Jun 2021, 08:18.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
Footnote F2
Restricted share units were granted on June 14, 2021 and vest on June 14, 2022.
Footnote F3
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.